PURPOSE: To disclose, using an ex vivo study, the histopathological mechanism behind in vivo thickening of the endothelium/Descemet membrane complex (En/DM) observed in rejected corneal grafts (RCGs). METHODS: Descemet membrane (DM), endothelium, and retrocorneal membranes make up the total En/DM thickness. These layers are not differentiable by high-definition optical coherence tomography; therefore, the source of thickening is unclear from an in vivo perspective. A retrospective ex vivo study (from September 2015 to December 2015) was conducted to measure the thicknesses of DM, endothelium, and retrocorneal membrane in 54 corneal specimens (31 RCGs and 23 controls) using light microscopy. Controls were globes with posterior melanoma without corneal involvement. RESULTS: There were 54 corneas examined ex vivo with mean age 58.1 ± 12.2 in controls and 51.7 ± 27.9 years in RCGs. The ex vivo study uncovered the histopathological mechanism of En/DM thickening to be secondary to significant thickening (P < 0.001) of DM (6.5 ± 2.4 μm) in RCGs compared with controls (3.9 ± 1.5 μm). CONCLUSIONS: Our ex vivo study shows that DM is responsible for thickening of the En/DM in RCGs observed in vivo by high-definition optical coherence tomography and not the endothelium or retrocorneal membrane.
PURPOSE: To disclose, using an ex vivo study, the histopathological mechanism behind in vivo thickening of the endothelium/Descemet membrane complex (En/DM) observed in rejected corneal grafts (RCGs). METHODS: Descemet membrane (DM), endothelium, and retrocorneal membranes make up the total En/DM thickness. These layers are not differentiable by high-definition optical coherence tomography; therefore, the source of thickening is unclear from an in vivo perspective. A retrospective ex vivo study (from September 2015 to December 2015) was conducted to measure the thicknesses of DM, endothelium, and retrocorneal membrane in 54 corneal specimens (31 RCGs and 23 controls) using light microscopy. Controls were globes with posterior melanoma without corneal involvement. RESULTS: There were 54 corneas examined ex vivo with mean age 58.1 ± 12.2 in controls and 51.7 ± 27.9 years in RCGs. The ex vivo study uncovered the histopathological mechanism of En/DM thickening to be secondary to significant thickening (P < 0.001) of DM (6.5 ± 2.4 μm) in RCGs compared with controls (3.9 ± 1.5 μm). CONCLUSIONS: Our ex vivo study shows that DM is responsible for thickening of the En/DM in RCGs observed in vivo by high-definition optical coherence tomography and not the endothelium or retrocorneal membrane.
Authors: K Aita; Y Yamaguchi; S Horita; M Ohno; K Tanabe; S Fuchinoue; S Teraoka; H Toma; M Nagata Journal: Am J Transplant Date: 2007-04 Impact factor: 8.086
Authors: Candice A Roufosse; Ian Shore; Jill Moss; Linda B Moran; Michelle Willicombe; Jack Galliford; Ka-kit K Chan; Paul A Brookes; Hanneke de Kort; Adam G McLean; David Taube; H Terence Cook Journal: Transplantation Date: 2012-08-15 Impact factor: 4.939
Authors: Mohamed Abou Shousha; Sonia H Yoo; Mohamed S Sayed; Sean Edelstein; Matthew Council; Ravi S Shah; Joshua Abernathy; Zachary Schmitz; Patrick Stuart; Rocio Bentivegna; Maria P Fernandez; Christopher Smith; Xiaotang Yin; George J Harocopos; Sander R Dubovy; William J Feuer; Jianhua Wang; Victor L Perez Journal: Am J Ophthalmol Date: 2017-03-02 Impact factor: 5.258
Authors: Christopher Smith; Daniel Kaitis; Jordan Winegar; Sean Edelstein; Matthew Council; George Kontadakis; Rocio Bentivegna; Mohamed Abou Shousha Journal: Ther Adv Ophthalmol Date: 2018-12-03
Authors: Taher Eleiwa; Amr Elsawy; Eyup Ozcan; Collin Chase; William Feuer; Sonia H Yoo; Victor L Perez; Mohamed F Abou Shousha Journal: Sci Rep Date: 2021-07-15 Impact factor: 4.379